TD Cowen analyst Jared Levine downgraded TriNet (TNET) to Hold from Buy with a price target of $74, down from $104, following the Q4 report.
TD Cowen analyst Andrew Kligerman maintained a Buy rating on Arch Capital Group (ACGL – Research Report) today and set a price target of ...
TD Cowen's 45 th Annual Health Care Conference is taking place March 3 - 5, 2025, at the Marriott Copley Place in Boston, MA.
CNBC’s Eamon Javers and TD Cowen’s Roman Schweizer, join 'The Exchange' to discuss Trump's comments on halving defense ...
TD Cowen adjusted its outlook on McDonald's Corporation (NYSE:MCD) shares, raising the price target from $300.00 to $305.00.
To access the live webcast of the panel presentation please visit the Events and Presentations page within the Ardelyx website at https://ir.ardelyx.com/events-and-presentations. A replay of the panel ...
Rion Aesthetics, a company at the forefront of exosome technology in the aesthetics industry, today announced its ...
TD Cowen has upgraded CRISPR Therapeutics (CRSP) to hold from sell, stating it now sees less downside to the stock. Read more ...
TD Cowen assumed coverage on shares of Ermenegildo Zegna (NYSE:ZGN – Free Report) in a report published on Tuesday morning, Marketbeat reports. The brokerage issued a hold rating and a $10.00 target ...
WASHINGTON — Processed food companies and federal nutrition guidelines and programs could be in the crosshairs of President Donald Trump’s new Make America Healthy Again (MAHA) Commission, according ...
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be ...
The page may have been moved or deleted. You can try searching for it below, move on or ask for help.